# Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds

> **NCT00564213** · PHASE4 · COMPLETED · sponsor: **Instituto de Olhos de Goiania** · enrollment: 36 (estimated)

## Conditions studied

- High Myopia

## Interventions

- **DRUG:** PRK and a single intraoperative topical application of mitomycin C 0.02% for 15 seconds

## Key facts

- **NCT ID:** NCT00564213
- **Lead sponsor:** Instituto de Olhos de Goiania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2008-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564213, "Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00564213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*